1
|
McKernan D, McDermott O. Industrial clusters, creating a strategy for continued success. Heliyon 2024; 10:e29220. [PMID: 38617911 PMCID: PMC11015453 DOI: 10.1016/j.heliyon.2024.e29220] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2023] [Revised: 01/18/2024] [Accepted: 04/03/2024] [Indexed: 04/16/2024] Open
Abstract
Purpose This study aims to describe and propose an effective strategy for an industrial cluster and investigates industrial cluster-promoted growth.Design/Methodology/Approach: A qualitative study was carried out within the Irish Medtech cluster with key stakeholders from the cluster. Findings The findings demonstrate significant opportunities for further cluster development and to potentially double the number of spin-outs and value of R&D investments while enhancing an entrepreneurial culture. This study also recommends that multiple agencies collaborate to achieve the future strategic objectives of the cluster. The soft infrastructure of regulatory and intellectual policies is as important as the hard infrastructure of roads and buildings. Practical implications This study has implications for government policy, informing how they align the local needs of compact industrial clusters with policies to make the Irish cluster more unique and gain a sustainable competitive advantage. The approach is applicable and has implications for all industrial clusters.Originality/Value: This is one of the first studies to look at the Irish Medtech cluster in terms of its shortcomings and future opportunities.
Collapse
Affiliation(s)
- David McKernan
- College of Science & Engineering, University of Galway, Ireland
| | | |
Collapse
|
2
|
Dooms M. Orphan medical devices have come a long way. Orphanet J Rare Dis 2023; 18:71. [PMID: 37020310 PMCID: PMC10077604 DOI: 10.1186/s13023-023-02685-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2022] [Accepted: 04/02/2023] [Indexed: 04/07/2023] Open
Abstract
BACKGROUND In many countries worldwide orphan drug regulations are installed but only the United States of America and Japan have an orphan device regulation. For many years surgeons have used off-label or self-assembled medical devices for the prevention, diagnosis or treatment of rare disorders. Four examples are given: an external cardiac pacemaker, a metal brace for clubfoot in newborns, a transcutaneous nerve stimulator and a cystic fibrosis mist tent. CONCLUSION In this article we argue that we need authorized medical devices as well as medicinal products to prevent, diagnose and treat patients with life-threatening or chronically debilitating disorders with a low prevalence/incidence. Several arguments are given to support this statement.
Collapse
Affiliation(s)
- M Dooms
- IRDiRC Working Group on MedTech for Rare Diseases, University Hospitals Leuven, Leuven, Belgium.
| |
Collapse
|
3
|
Grassi L, Fantaccini S. An overview of Fintech applications to solve the puzzle of health care funding: state-of-the-art in medical crowdfunding. Financ Innov 2022; 8:84. [PMID: 36158456 PMCID: PMC9483272 DOI: 10.1186/s40854-022-00388-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/03/2021] [Accepted: 09/09/2022] [Indexed: 06/16/2023]
Abstract
Crowdfunding is emerging as an alternative form of funding for medical purposes, with capital being raised directly from a broader and more diverse audience of investors. In this paper, we have systematically researched and reviewed the literature on medical crowdfunding to determine how crowdfunding connects with the health care industry. The health care industry has been struggling to develop sustainable research and business models for economic systems and investors alike, especially in pharmaceuticals. The research results have revealed a wealth of evidence concerning the way crowdfunding is applied in real life. Patients and caregivers utilize web platform-based campaigns all over the world to fund their medical expenses, generally on a spot basis, using donation-based or even reward-based schemes, regardless of the health care system archetype (public, private insurance-based or hybrid). Academics have also focused on funding campaigns and the predictors of success (which range from social behaviour and environment to the basic demographics of the campaigners and their diseases) and on social and regulatory concerns, including heightened social inequality and stigma. While equity crowdfunding is disrupting the way many ventures/businesses seek capital in the market, our research indicates that there are no relevant or consistent data on the practice of medical equity crowdfunding in health care, apart from a few anecdotal cases.
Collapse
Affiliation(s)
- Laura Grassi
- School of Management, Politecnico di Milano, Milan, Italy
| | | |
Collapse
|
4
|
Denend L, McCutcheon S, Regan M, Sainz M, Yock P, Azagury D. Analysis of Gender Perceptions in Health Technology: A Call to Action. Ann Biomed Eng 2020; 48:1573-1586. [PMID: 32078709 PMCID: PMC7154023 DOI: 10.1007/s10439-020-02478-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Accepted: 02/10/2020] [Indexed: 11/23/2022]
Abstract
Gender diversity has been linked to positive business results. Yet limited data exist to characterize the gender landscape in health technology, a field that draws employees from both biomedical engineering and medicine. To better understand the state of gender diversity in this industry, we developed a survey to explore leadership representation and perceptions of workplace equality, job satisfaction, and work-life balance. Data from 400 + health technology professionals revealed that women are significantly underrepresented in senior leadership and that men and women experience the workplace differently. Men believe in greater numbers than females that senior leaders are focused on recruiting and promoting women, promotion criteria are equitable, and the major barrier to leadership roles for women is work/family balance. In contrast, women perceive a less meritocratic and inclusive workplace in which their ability to rise is hampered by exclusion from influential communication networks and stereotyping/bias. Perhaps as a result, more than one-third of female respondents are considering leaving their current jobs, citing dissatisfaction with management and a desire for greater advancement opportunities. This study highlights significant gender perception differences in health technology that require further study and proactive remediation for the field to fully realize the benefits of gender diversity.
Collapse
Affiliation(s)
- Lyn Denend
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, E100, Stanford, CA, 94305, USA.
| | - Stacey McCutcheon
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, E100, Stanford, CA, 94305, USA
| | - Mike Regan
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, E100, Stanford, CA, 94305, USA
| | - Maria Sainz
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, E100, Stanford, CA, 94305, USA
| | - Paul Yock
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, E100, Stanford, CA, 94305, USA
| | - Dan Azagury
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, E100, Stanford, CA, 94305, USA
| |
Collapse
|
5
|
Steinberger JD, Denend L, Azagury DE, Brinton TJ, Makower J, Yock PG. Needs-Based Innovation in Interventional Radiology: The Biodesign Process. Tech Vasc Interv Radiol 2017; 20:84-89. [PMID: 28673651 DOI: 10.1053/j.tvir.2017.04.006] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
There are many possible mechanisms for innovation and bringing new technology into the marketplace. The Stanford Biodesign innovation process is based in a deep understanding of clinical unmet needs as the basis for focused ideation and development. By identifying and vetting a compelling unmet need, the aspiring innovator can "derisk" a project and maximize chances for successful development in an increasingly challenging regulatory and economic environment. As a specialty founded by tinkerers, with a history of disruptive innovation that has yielded countless new ways of delivering care with minimal invasiveness, lower morbidity, and lower cost, interventional radiologists are uniquely well positioned to identify unmet needs and develop novel solutions free of dogmatic convention.
Collapse
Affiliation(s)
| | - Lyn Denend
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, Stanford, CA
| | - Dan E Azagury
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, Stanford, CA
| | - Todd J Brinton
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, Stanford, CA
| | - Josh Makower
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, Stanford, CA; ExploraMed Development LLC, Mountain View, CA; NEA, Chevy Chase, MD
| | - Paul G Yock
- Stanford Byers Center for Biodesign, Stanford University, 318 Campus Drive, Stanford, CA
| |
Collapse
|
6
|
|